Navigation Links
Kendle Announces Details Regarding Fourth Quarter and Full-Year 2008 Earnings and 2009 Guidance Release, Webcast and Conference Call
Date:2/4/2009

CINCINNATI, Feb. 4 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL) announced today that it will release its fourth quarter 2008 financial results after the market closes on Tuesday, Feb. 24, 2009. The Company will host a telephone conference call and simultaneous webcast on Wednesday, Feb. 25 at 8:30 a.m. Eastern Time. A question and answer session will follow.

Conference Call Instructions

To participate in the telephone conference call, interested parties in the United States and Canada should dial (800) 399-0069. Participants outside North America should dial (706) 643-3694. A replay will be available through 5 p.m. Eastern Time on Mar. 25, 2009 by dialing (706) 645-9291 and entering conference ID number 80512141.

Webcast Instructions

To access the live webcast, visit the company Web site at www.kendle.com or link to the Webcast directly at http://www.videonewswire.com/event.asp?id=55622. Instructions for accessing the webcast are provided at both sites. The webcast will be archived at www.kendle.com (click on "Investors" and then "Events & Presentations") shortly after the call for on-demand replay through 5 p.m. Eastern Time on Mar. 25, 2009. Please note that webcast participants will not be able to ask questions.

System requirements for the webcast include Windows Media Player software and at least a 28.8 Kbps connection to the Internet. Media Player is downloadable at no charge from http://www.microsoft.com/windows/windowsmedia/default.aspx.

About Kendle

Kendle Internatio
'/>"/>

SOURCE Kendle International Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Kendle to Present at the 2008 Raymond James Boston Fall Investors Conference
2. Kendle to Present at the 2008 Credit Suisse Health Care Conference
3. Kendle Reappoints Former CFO Timothy M. Mooney to Board of Directors
4. Kendle Named a Best Place to Work in Greater Cincinnati
5. Kendle Reports Record 3Q 08 Net Income and Total Business Authorizations
6. Kendle Named to FORTUNE List of 100 Fastest-Growing Companies for 2008
7. Kendle to Present at the UBS Global Life Sciences Conference
8. Kendle Invites You to Attend its Second Quarter 2008 Earnings Conference Call and Webcast
9. Kendle to Host Conference Call and Webcast to Discuss DecisionLine Acquisition and Provide Update on Second Quarter Progress
10. Kendle Expands Global Clinical Pharmacology Capabilities with Acquisition of DecisionLine Clinical Research Corporation
11. Kendle Appoints Patricia Williams Vice President, Commercial Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... , Dec. 16, 2014  Vermillion, Inc. (NASDAQ: ... on gynecologic disease, today announced the next step in ... premier bio-analytics solutions provider with the naming of current ... and Chief Executive Officer, while current Chairman of the ... to serve as Chairman. These changes are effective January ...
(Date:12/17/2014)... 17, 2014 CASI Pharmaceuticals, Inc. (Nasdaq: ... acquisition, development and commercialization of innovative therapeutics addressing cancer ... with a primary commercial focus on China ... a Type C meeting with the U.S. Food and ... held in February 2015.  During this meeting the Company ...
(Date:12/17/2014)... --  Synageva BioPharma Corp. (NASDAQ: GEVA ... disorders, announced today its presentation at the upcoming J.P. ... Francisco, CA. Sanj K. ... on Monday, January 12, 2015, at 9:00 a.m. PST ... and may be accessed from the "Webcasts & Presentations" ...
(Date:12/15/2014)... Israel , Dec. 15, 2014  BrainStorm ... leading developer of adult stem cell technologies for neurodegenerative ... Ltd. was awarded a grant of approximately $1.1 million ... Chief Scientist (OCS).  This is the eighth year that ... the Office of the Chief Scientist, which is part ...
Breaking Biology Technology:Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3
... Pharma AG, today,announced a substantial expansion of its ... Medical Officer and Head of Global Clinical,Development, Dr. ... Dr,Hans Rensland as Vice President Regulatory Affairs, Dr. ... Dr. Markus Vogt as Vice,President of Quality and ...
... A combination of two drugs can selectively block pain-sensing ... such as touch, according to a new study by ... suggests an improved way to treat pain from childbirth ... new treatments to help the millions of Americans who ...
... Troy J. Campione, Ph.D., Joins Solazyme Executive Team, ... Solazyme, a,bioscience company pioneering biofuels and health/wellness products ... the position of senior,vice president of business development. ... finalization of,partnership agreements and contracts with major companies. ...
Cached Biology Technology:Nitec Pharma Expands Senior Management Team 2Nitec Pharma Expands Senior Management Team 3Nitec Pharma Expands Senior Management Team 4Treatment blocks pain without disrupting other functions 2Treatment blocks pain without disrupting other functions 3Solazyme Announces New Senior Vice President of Business Development 2
(Date:11/18/2014)... Nov. 18, 2014   EyeLock Inc. , ... and MorphoTrust USA (Safran), a leading ... announced a strategic partnership to offer comprehensive biometric ... administration (MVA), airport screening and financial services markets. ... MorphoTrust serves consumers through a nationwide network of ...
(Date:11/12/2014)... Fla. , Nov. 12, 2014 Crossmatch™, ... today that its U.are.U ® fingerprint readers have ... chain in Central Mexico . The ... 2014 to eliminate payroll issues caused by employees clocking ... installing the U.are.U fingerprint readers, Montparnasse relied on paper ...
(Date:11/10/2014)... appearing on U.S. store shelves in early 2010, and ... The small packets can be tossed into a washing ... or powder. The convenience, though, has come with risks ... at Nationwide Children,s Hospital found that from 2012 through ... children younger than 6 years of age swallowing, inhaling, ...
Breaking Biology News(10 mins):EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3Montparnasse Pasteleria Achieves Time and Attendance Transparency with Crossmatch U.are.U Fingerprint Readers 2Study finds laundry detergent pods, serious poisoning risk for children 2
... GBIF Campaign? , Different users of the GBIF network ... of various types. Given the small size and coordination ... central activities to meet all of these needs. However, ... the GBIF network do coincide with the needs of these ...
... wont be making a stop at the Smithsonians National ... with love and romance, mating and dating at the ... encounter. Successful breeding is often much more complicated ... nature to take its course. Animals in captivity need ...
... coursing through the veins of men living in the North ... has been just published. Focusing on the Wirral in ... surnames were in existence as far back as medieval times, ... specifically linked to Scandinavian ancestry. The collaborative study, by ...
Cached Biology News:4 GBIF-endorsed campaigns underway 24 GBIF-endorsed campaigns underway 34 GBIF-endorsed campaigns underway 44 GBIF-endorsed campaigns underway 5Science, not romance, controls mating at Smithsonian's National Zoo 2Science, not romance, controls mating at Smithsonian's National Zoo 3Unravelling the Northwest's Viking past 2
... epitope recognized by A300-183A maps ... 5 of human quaking homolog ... 9444). The epitope is ... 2, 3, 4, 6, 7 ...
... ml Dynabeads Epoxy (4.5 m). Hydrophobic ... groups. Ideal for coupling of antibodies for ... initial coupling with covalent binding of primary ... groups (SH)) occurring within 16-20 hours. Coupling ...
Flotillin-2 (ESA) Purified Anti-Mouse, Anti-Rat, Anti-Human, Anti-Dog, Anti-Chicken clone 29, Isotype Mouse IgG 1 , 150 µg Consult technical datasheet for details....
St. Louis encephalitis Immunogen: St. Louis encephalitis. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: